Company intelligence / Profile preview

Ilsim Pharmaceutical

Dalseo-gu, Daegu, South Koreailshimph.co.kr ↗

Ownership: Private
Development stage: Other

Overview

Ilsim Pharmaceutical Co., Ltd. (also known as Ilshim Pharm) was a South Korean pharmaceutical company founded in 1959 and headquartered in Daegu. The company specialized in the development, manufacturing, and commercialization of traditional Korean herbal medicines (oriental medicine formulations) and over-the-counter (OTC) drugs, including granules, pills, and capsules. In 1995, it received Korea Good Manufacturing Practice (KGMP) certification for its manufacturing facilities. Following regulatory challenges and administrative penalties, the company officially closed its operations on December 2, 2025.

Therapeutic areas: PsychiatryNeurologyInfectious DiseasesGastroenterologyImmunology
Modalities: Herbal medicineBotanical extractPlant extractSmall molecule
Industry: Pharma

Beyond the preview

Go deeper on Ilsim Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ilsim Pharmaceutical.